Call for more patient-centered drug development in oncology — NEJM

In an article in the New England Journal of Medicine (NEJM), published online on 3 July 2013, Dr Ethan Basch highlights the lack of information on how a drug will make patients feel in the US label of most new cancer drugs.  … Continue reading

Pharma’s return to growth: EvaluatePharma

On 26 June, EvaluatePharma released their “World Preview: 2013” report which forecasts a return to return to growth of the global biopharma market – in contrast to their prediction of unprecedented market contraction in the 2012 report.  It seems that we … Continue reading

EMA draft policy on access to clinical trial data

On Monday, 24 June 2013, the European Medicines Agency (EMA) published their draft policy on publication and access to clinical trial data.  The policy is open for public consultation until 30 September 2013. EMA were recently prevented from releasing clinical … Continue reading